BAM Logo

HLA B27 Status

EPTIS factsheet 790709 | Last revision 2020-10-26 | URL: https://www.eptis.bam.de/pts790709 https://www.eptis.bam.de/pts790709

PT provider
Based in Australia
Language(s) English
Remarks The material assayed is fresh whole blood, which quickly deteriorates under normal transport conditions and should be tested within 48 hours of dispatch. As such this program is only available to a limited number of destinations outside Australia, New Zealand and Malaysia. Please contact Customer Service at customer.service@rcpaqap.com.au if you are outside these areas.
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
EDTA whole blood Human Leukocyte Antigen B27 (HLA B27) -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Yes
Regularly operated Yes (1 case per survey/8 surveys)
Year of first operation
Contact details of the PT provider
Provider Contact person
Suite 201/8 Herbert Street
St Leonards, 2065

Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Web: https://www.rcpaqap.com.au/ https://www.rcpaqap.com.au/
Mr Rhys Judd
Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Email: rhys.judd@rcpaqap.com.au rhys.judd@rcpaqap.com.au
If you find any mistakes please contact the responsible EPTIS coordinator in Australia, Ms Luminita Antin. Ms Luminita Antin.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5